76
|
257
|
2weoA |
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors |
70
|
230
|
2w3nA |
Structure and inhibition of the co2-sensing carbonic anhydrase can2 from the pathogenic fungus cryptococcus neoformans |
76
|
258
|
2vvbX |
Human carbonic anhydrase ii in complex with bicarbonate |
77
|
258
|
2vvaX |
Human carbonic anhydrase in complex with co2 |
78
|
268
|
2w2jA |
Crystal structure of the human carbonic anhydrase related protein viii |
76
|
257
|
2qoaA |
Crystal structure of the complex of hcaii with an indane-sulfonamide inhibitor |
76
|
258
|
2qp6A |
The crystal structure of the complex of hcaii with a bioreductive antitumor derivative |
76
|
259
|
2qo8A |
Crystal structure of the complex of hcaii with an indane-sulfonamide inhibitor |
75
|
256
|
2q38A |
Carbonic anhydrase ii in complex with saccharin at 1.95 angstrom |
77
|
256
|
2q1bA |
Carbonic anhydrase ii in complex with saccharin |
73
|
257
|
2powA |
The crystal structure of the human carbonic anhydrase ii in complex with 4-amino-6-trifluoromethyl-benzene-1,3-disulfonamide |
77
|
257
|
2q1qA |
Carbonic anhydrase inhibitors. interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and x-ray crystallographic studies |
75
|
258
|
2pouA |
The crystal structure of the human carbonic anhydrase ii in complex with 4,5-dichloro-benzene-1,3-disulfonamide |
74
|
257
|
2povA |
The crystal structure of the human carbonic anhydrase ii in complex with 4-amino-6-chloro-benzene-1,3-disulfonamide |
74
|
257
|
2osfA |
Inhibition of carbonic anhydrase ii by thioxolone: a mechanistic and structural study |
76
|
256
|
2o4zA |
Crystal structure of the carbonic anhydrase ii complexed with hydroxysulfamide inhibitor |
75
|
258
|
2osmA |
Inhibition of carbonic anhydrase ii by thioxolone: a mechanistic and structural study |
73
|
258
|
2nn1A |
Structure of inhibitor binding to carbonic anhydrase i |
74
|
258
|
2nxsA |
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii |
74
|
258
|
2nmxA |
Structure of inhibitor binding to carbonic anhydrase i |
73
|
258
|
2nwpA |
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii |
78
|
258
|
2nxrA |
Structural effects of hydrophobic mutations on the active site of human carbonic anhydrase ii |
75
|
258
|
2nwoA |
Structural and kinetic effect of hydrophobic mutations in the active site of human carbonic anhydrase ii |
77
|
258
|
2nngA |
Structure of inhibitor binding to carbonic anhydrase ii |
76
|
258
|
2nwzA |
Structural and kinetic effects of hydrophobic mutations on the active site of human carbonic anhydrase ii |
77
|
259
|
2nnsA |
Structure of inhibitor binding to carbonic anhydrase ii |
76
|
258
|
2nwyA |
Structural and kinetic effects of hydrophobic mutations on the active site of human carbonic anhydrase ii |
74
|
259
|
2nnvA |
Structure of inhibitor binding to carbonic anhydrase ii |
79
|
258
|
2nxtA |
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii |
76
|
259
|
2nnoA |
Structure of inhibitor binding to carbonic anhydrase ii |
74
|
258
|
2nn7A |
Structure of inhibitor binding to carbonic anhydrase i |
71
|
256
|
2it4A |
X ray structure of the complex between carbonic anhydrase i and the phosphonate antiviral drug foscarnet |
74
|
258
|
2hocA |
Crystal structure of the human carbonic anhydrase ii in complex with the 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide inhibitor |
76
|
258
|
2iliA |
Refine atomic structure of human carbonic anhydrase ii |
76
|
257
|
2hl4A |
Crystal structure analysis of human carbonic anhydrase ii in complex with a benzenesulfonamide derivative |
68
|
257
|
2hfwA |
Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase iii |
74
|
257
|
2hd6A |
Crystal structure of the human carbonic anhydrase ii in complex with a hypoxia-activatable sulfonamide. |
0
|
9
|
2hkfP |
Crystal structure of the complex fab m75- peptide |
78
|
256
|
2hkkA |
Carbonic anhydrase activators: solution and x-ray crystallography for the interaction of andrenaline with various carbonic anhydrase isoforms |
74
|
257
|
2hncA |
Crystal structure of the human carbonic anhydrase ii in complex with the 5-amino-1,3,4-thiadiazole-2-sulfonamide inhibitor. |
75
|
257
|
2h4nA |
H94n carbonic anhydrase ii complexed with acetazolamide |
77
|
256
|
2h15A |
Carbonic anhydrase inhibitors: clashing with ala65 as a means of designing isozyme-selective inhibitors that show low affinity for the ubiquitous isozyme ii |
75
|
257
|
2gehA |
N-hydroxyurea, a versatile zinc binding function in the design of metalloenzyme inhibitors |
80
|
257
|
2gd8A |
Crystal structure analysis of the human carbonic anhydrase ii in complex with a 2-substituted estradiol bis-sulfamate |
74
|
257
|
2foqA |
Human carbonic anhydrase ii complexed with two-prong inhibitors |
79
|
257
|
2fmgA |
Carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine and crystallographic analysis of their adducts with isozyme ii: sterospecific recognition within the active site of an enzyme and its consequences for the drug design, structure with l-phenylalanine |
74
|
259
|
2fovA |
Human carbonic anhydrase ii complexed with two-prong inhibitors |
78
|
258
|
2fnnA |
Activation of human carbonic anhydrase ii by exogenous proton donors |
75
|
260
|
2fouA |
Human carbonic anhydrase ii complexed with two-prong inhibitors |
80
|
257
|
2fmzA |
Carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine, structure with d-phenylalanine. |